4.7 Article

Akt inhibitor augments anti-proliferative efficacy of a dual mTORC1/2 inhibitor by FOXO3a activation in p53 mutated hepatocarcinoma cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, Research & Experimental

Inhibition of p70 isoforms of S6K1 induces anoikis to prevent transformed human hepatocyte growth

Tapas Patra et al.

Summary: Inhibition of p70-S6K1 altered cell growth, cell cycle progression, and tumor growth while reducing markers related to hepatocellular carcinoma. This suggests that targeting the p70 isoform of S6K1 may be a promising therapeutic approach for HCC treatment in conjunction with other therapies.

LIFE SCIENCES (2021)

Review Cell Biology

Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches

Eduardo Alvarado-Ortiz et al.

Summary: Frequent p53 mutations not only abolish tumor suppressor capacities but also confer various gain-of-function activities that impact key pathways in tumor development and progression. The effects of these mutations on proliferation, migration, metabolic reprogramming, and immune evasion constitute major driving forces for human tumors. The interaction of mutp53 with molecules such as AMPK and SREBP1 leads to metabolic reprogramming and favors anabolic pathways in cancer cells.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Oncology

Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma

Qianhui Xu et al.

Summary: This study revealed a positive correlation between TMB value and older age, male gender, and early T status in HCC. A risk score based on three hub genes significantly influenced overall survival time, immune cell infiltration, and ICB-related hub targets. The prognostic performance of the risk score was validated in an external testing group, and a risk-clinical nomogram was constructed for clinical application. HTRA3 was identified as a prognostic factor in HCC, and TP53 mutation did not interfere with the risk score-based prognostic prediction.

CANCER CELL INTERNATIONAL (2021)

Article Oncology

Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline

John D. Gordan et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

Mutant p53 as a guardian of the cancer cell

Fiamma Mantovani et al.

CELL DEATH AND DIFFERENTIATION (2019)

Review Oncology

Molecular therapies and precision medicine for hepatocellular carcinoma

Josep M. Llovet et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Review Biochemistry & Molecular Biology

How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?

Brandon J. Aubrey et al.

CELL DEATH AND DIFFERENTIATION (2018)

Article Oncology

mTORC2 Promotes Tumorigenesis via Lipid Synthesis

Yakir Guri et al.

CANCER CELL (2017)

Review Biochemistry & Molecular Biology

Putting p53 in Context

Edward R. Kastenhuber et al.

Article Biochemistry & Molecular Biology

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

Adrian Ally et al.

Review Gastroenterology & Hepatology

Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends

Matthias S. Matter et al.

JOURNAL OF HEPATOLOGY (2014)

Article Genetics & Heredity

Trans-ancestry mutational landscape of hepatocellular carcinoma genomes

Yasushi Totoki et al.

NATURE GENETICS (2014)

Article Gastroenterology & Hepatology

Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma

Augusto Villanueva et al.

GASTROENTEROLOGY (2008)

Article Biochemistry & Molecular Biology

Biochemical and Structural Characterization of an Intramolecular Interaction in FOXO3a and Its Binding with p53

Feng Wang et al.

JOURNAL OF MOLECULAR BIOLOGY (2008)

Article Cell Biology

ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

Jer-Yen Yang et al.

NATURE CELL BIOLOGY (2008)

Article Multidisciplinary Sciences

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

DD Sarbassov et al.

SCIENCE (2005)

Article Cell Biology

HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation

BHP Zhou et al.

NATURE CELL BIOLOGY (2001)

Article Biochemistry & Molecular Biology

Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a)

A Brunet et al.

MOLECULAR AND CELLULAR BIOLOGY (2001)